Bokf, Na Nevro Corp Transaction History

Bokf, Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$44.22 - $75.47 $218,800 - $373,425	-4,948 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$72.38 - $92.5 $147,655 - $188,700	2,040 Added 70.15%	4,948 $395,000
Q1 2018 May 14, 2018	BUY	$69.46 - $88.57 $40,425 - $51,547	582 Added 25.02%	2,908 $252,000
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $11,539 - $16,329	175 Added 8.14%	2,326 $161,000
Q3 2017 Nov 14, 2017	SELL	$80.87 - $91.08 $18,438 - $20,766	-228 Reduced 9.58%	2,151 $196,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,379	2,379 $177,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $134M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.